awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28077785-2DACBEBF-A68B-4967-8F80-6584AFABB3CC
Q28077785-2DACBEBF-A68B-4967-8F80-6584AFABB3CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077785-2DACBEBF-A68B-4967-8F80-6584AFABB3CC
Mechanism of c-MET in Non-small Cell Lung Cancer and Its Treatment and Testing
P2860
Q28077785-2DACBEBF-A68B-4967-8F80-6584AFABB3CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077785-2DACBEBF-A68B-4967-8F80-6584AFABB3CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
42b17a0cf0869e7077e70e00c3cec52e059fa0ec
P2860
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.